Free Trial
ASX:IDX

Integral Diagnostics (IDX) Stock Price, News & Analysis

Integral Diagnostics logo

About Integral Diagnostics Stock (ASX:IDX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
240,828 shs
Average Volume
N/A
Market Capitalization
A$1.10 billion
P/E Ratio
N/A
Dividend Yield
1.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

IDX Stock News Headlines

Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
See More Headlines

IDX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Integral Diagnostics investors own include electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Credit Suisse Group (CS), Chimerix (CMRX), Capricor Therapeutics (CAPR) and Bathurst Resources (BRL).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:IDX
CIK
N/A
Fax
N/A
Employees
2,010
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.39
Net Income
-A$60.70 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$469.70 million
Price / Cash Flow
23.99
Book Value
A$1.29 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$1.10 billion
Optionable
Not Optionable
Beta
0.73
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (ASX:IDX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners